Differential Effects of Glycolipid Biosynthesis Inhibitors on Ceramide‐Induced Cell Death in Neuroblastoma Cells
Authors:
Open Access
- 1 March 1999
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 72 (3) , 1040-1049
Abstract
: An in vitro model of Gaucher's disease in murine neuroblastoma X rat glioma NG108‐15 cells was used to investigate the physiological effects of two specific inhibitors of glucosylceramide synthase, d,l‐threo‐1‐phenyl‐2‐decanoylamino‐3‐morpholino‐1‐propanol (d,l‐PDMP) and N‐butyldeoxynojirimycin (NB‐DNJ), which have been suggested as agents for treatment of glycolipid storage disorders. Incubation of NG108‐15 cells with conduritol‐B‐epoxide, a covalent inhibitor of glucosylce‐ramidase, raised the intracellular concentration of glucosylceramide (GC) by more than fourfold, indicating a glycolipid composition equivalent to that of Gaucher's cells. The level of GC was decreased, and the cells were depleted of gangliosides by postincubation with d,l‐PDMP or NB‐DNJ. Treatment with d,l‐PDMP, but not with NB‐DNJ, resulted in a dose‐dependent reduction of the growth rate and eventually caused cell death in NG108‐15 cells on reaching confluency. An in situ detection assay using terminal nucleotidyltransferase indicated that cell degeneration was accompanied by apoptosis. Lipid analysis by high‐performance TLC revealed that on incubation with d,l‐PDMP, but not with NB‐DNJ, the concentration of endogenous ceramide was elevated by threefold. Ceramide elevation and apoptosis were also observed when NG108‐15 cells were incubated with daunorubicin, which was previously reported to induce programmed cell death by stimulation of ceramide synthesis. Structural characterization by HPLC and subsequent laser desorption mass spectrometry revealed that the endogenous ceramide contained fatty acids with chain lengths ranging from C14 : 0 to C24 : 0. The results indicate that elevation of levels of these ceramide species by incubation with d,l‐PDMP or daunorubicin induces programmed cell death in NG108‐15 cells. Because ceramide accumulation and cell death were not observed on incubation with NB‐DNJ, its use is suggested to be less toxic than that of d,l‐PDMP for treatment of Gaucher's disease and other sphingolipid storage disorders.Keywords
This publication has 52 references indexed in Scilit:
- Induction of Apoptosis by Sphingosine-1-Phosphate in Human Hepatoma Cells Is Associated with Enhanced Expression of bax Gene ProductBiochemical and Biophysical Research Communications, 1996
- Ceramide signalling and the immune responseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Gaucher disease: studies of phenotype, molecular diagnosis and treatmentClinical Genetics, 1996
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- Clear differences in ceramide metabolism between glycosphingolipids and sphingomyelin in a human promyelocytic leukemia cell line HL‐60 stimulated by a differentiation inducerFEBS Letters, 1995
- Induction of apoptotic DNA fragmentation and cell death by natural ceramideFEBS Letters, 1995
- A ceramide analogue (PDMP) inhibits glycolipid synthesis in fish embryosExperimental Cell Research, 1992
- Intracellular Activity of Lysosomal Glucosylceramidase Measured with 4-Nonylumbelliferyl β-glucosideBiological Chemistry Hoppe-Seyler, 1989
- Phenotypic changes in 3T3 cells associated with the change of sphingolipid synthesis by a ceramide analog, 2‐decanoylamino‐3‐morpholino‐1‐phenylpropanol (compound RV538)FEBS Letters, 1988
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957